HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
BRII-B(02137) spent HKD 231,000 to repurchase 200,000 shares on January 16th.
16/01/2025
GMT Eight
BRII-B (02137) announced on January 16, 2025, that the company spent 231,000 Hong Kong dollars to repurchase 200,000 shares.
Chengda Pharmaceuticals (301201.SZ) announces an expected net loss of 21 million to 29 million yuan in 2024, a change from profit to loss year on year.
Zhuzhou Kibing Group (601636.SH) issues a profit warning, with an expected net profit of 330 million to 410 million yuan in 2024, a year-on-year decrease of 81.15% to 76.58%.
RECOMMEND
American Economy: Stagflation or Recession?
1 h ago
Ping An Securities: Economic "stagflation" expectations are warming up, coupled with downward revisions in performance expectations. There is still pressure for further correction in the US stock market.
1 h ago
China Securities Co., Ltd.: The mid-term trend of revaluation of Chinese assets confidence is expected to continue. The technology growth sector is still the main driver in the mid-term.
1 h ago
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com